Searchable abstracts of presentations at key conferences in endocrinology

ea0049oc7.2 | Cardiovascular endocrinology (1) | ECE2017

Targeted molecular markers derived from genomic classification for adrenocortical cancer prognostication

Jouinot Anne , Assie Guillaume , Fassnacht Martin , Libe Rossella , Dousset Bertrand , Ronchi Silviu Sbiera Cristina , Kroiss Matthias , Korpershoek Esther , De Krijger Ronald , Waldmann Jens , Quinkler Marcus , Tabarin Antoine , Chabre Olivier , Luconi Michaela , Mannelli Massimo , Groussin Lionel , Baudin Eric , Amar Laurence , Beuschlein Felix , Bertherat Jerome

Background: Adrenocortical cancer (ACC) is an aggressive tumour with heterogeneous prognosis. Recently integrated genomics reported distinct genomic alterations: transcriptome “C1A” (high expression of proliferation/cell cycle-related genes) vs “C1B”, “CIMP” (CpG islands hypermethylation) vs “non-CIMP”, chromosome alterations “Noisy” (numerous and anarchic alterations) vs “Chromosomal” (extended patterns of loss of he...

ea0049ep1218 | Clinical case reports - Thyroid/Others | ECE2017

Thyroid nodule size at ultrasound as a predictor of malignancy

Gallardo Gema Lopez , Sastre Julia , Gonzalez Abel , Arranz Sandra , Silva Julia , Valero Miguel Angel , Aranda Jaime

Introduction: Most thyroid nodules are benign. Some studies have shown largest nodule size, specially >4 cm, can predict malignancy and reduce fine needle aspiration (FNA) accuracy. Recent studies, however, have shown conflicting results as to whether nodule size may be used to distinguish at risk-lesions. We attempt to determine whether nodule size predicts thyroid malignancy and to examine accuracy of fine needle aspiration (FNA) by size.Material a...

ea0041ep501 | Diabetes complications | ECE2016

Observational and retrospective study to analyze the changes in lipid and glycemic profiles in patients with metabolic syndrome after treatment with statins: ESMET study

del Canizo-Gomez Francisco Javier , Guinea-Lopez Rosario

The diabetogenic risk associated with statin therapy is higher in patients with pre-existing risk factors, such as metabolic syndrome (MS).Objective: To assess changes in lipid and glycemic profile in dyslipidemic subjects with MS after statin therapy.Methods: Observational, retrospective, multi-center study, conducted in 40 endocrinology Spanish hospitals. Each endocrinologist included the first 10 patients >18 years with MS, ...

ea0041ep625 | Endocrine tumours and neoplasia | ECE2016

Four cases of hyperparathyroidism-jaw tumor syndrome in young patients with primary hyperparathyroidism in Russia

Mamedova Elizaveta , Mokrysheva Natalya , Pigarova Ekaterina , Voronkova Iya , Vasilyev Evgeny , Petrov Vasily , Rozhinskaya Liudmila , Tiulpakov Anatoly

Introduction: Hyperparathyroidism-jaw tumor (HPT-JT) syndrome is a rare autosomal-dominant disorder caused by mutations in CDC73 tumor suppressor gene. To date about 80 mutations in CDC73 have been described.Case reports: Four patients among a cohort of young patients (<40 y.o.) with primary hyperparathyroidism (PHPT) underwent next-generation sequencing (NGS) (Ion TorrentTM PGMTM, Thermo Fisher Scientific&#150...

ea0059p008 | Adrenal and steroids | SFEBES2018

Post-operative haemodynamic instability after adrenalectomy for phaeochromocytoma: is routine intensive care admission necessary?

Thompson Joseph , Bennett Davinia , Ayuk John , Karavitaki Niki , O'Reilly Michael , Arlt Weibke , Sutcliffe Robert

Introduction: UK guidelines state that all patients undergoing adrenalectomy for phaeochromocytoma must be admitted to intensive care post-operatively due to the risk of haemodynamic instability (HDI). Intensive care beds are a scarce resource and it is important to regularly evaluate the need for admission, preventing unnecessary admission.Methods: The study population included all patients who underwent adrenalectomy for phaeochromocytoma at a UK terti...

ea0037ep460 | Diabetes (complications &amp; therapy) | ECE2015

Establishing the relationship between third-trimester foetal abdominal circumference, birthweight, and neonatal morbidity in gestational diabetes

Pereira Maria Teresa , Garrido Susana , Almeida Raquel , Vilaverde Joana , Pichel Fernando , Pinto Clara , Goncalves Joaquim , Dores Jorge

Introduction: Gestational diabetes (GD) is associated with a significantly higher risk of perinatal complications. It has been suggested that third-trimester (3thT) foetal abdominal circumference (fAC) determination is an important predictor of macrossomia and large for gestational age (LGA).Aims: The purpose of this study was to evaluate the association between the 3thT fAC percentile with birthweight (BW) and adverse neonatal outc...

ea0037ep1044 | Thyroid (non-cancer) | ECE2015

Usefulness of the assessment of thyroid blood flow as a predictor of relapse of Graves' disease

Merchante Agustin Angel , Garcia-Blasco Lourdes , Perez Susana , Fabra Amparo , Cubells Pilar , Sanchez Carlos

Objective: We investigated the clinical usefulness of thyroid blood flow measurement by colour-flow Doppler ultrasonography in predicting relapse of Graves’ disease (GD).Patients and methods: In 30 euthyroid GD patients, (eight males and 23 females), aged 17–68 years (mean 43.8±12.8), after at least 1 year of treatment with anti-thyroid drug (ATD) and just before its withdrawal, we evaluate with colour-flow Doppler ultrasonography the colo...

ea0035oc2.1 | Adrenal clinical | ECE2014

Armadillo repeat containing 5 gene (ARMC5) alterations in a large cohort of 98 ACTH-independant macronodular adrenal hyperplasia (AIMAH) patients: genotype/phenotype correlations.

Libe Rossella , Assie Guillaume , Espiard Stephanie , Luscap Windy , Guignat Laurence , Barrande Gaelle , Brucker-Davis Francoise , Doullay Francoise , Lopez Stephanie , Sonneta Emmanuel , Torremocha Florence , Pinsard Denis , Chabert-Buffet Nathalie , Sanson Marie Laure Raffin , Groussin Lionel , Borson-Chazot Francoise , Bertagna Xavier , Beuschlein Felix , Ragazzon Bruno , Bertherat Jerome

Introduction: ACTH-independent macronodular adrenal hyperplasia (AIMAH) is often an incidental finding, but may be diagnosed in patients with Cushing’s syndrome. We have recently identified germline mutations in the armadillo repeat containing 5 gene (ARMC5) in AIMAH patients, associated with somatic second hits specific of each AIMAH nodule ( Assié et al, NEJM, 2013). The aim is to characterize the prevalence of ARMC5 mutations in AIMAH patients and the gen...

ea0070aep217 | Bone and Calcium | ECE2020

The Burden of chronic hypoparathyroidism in canada: A retrospective study using the institute for clinical evaluative sciences (ices) database

A Khan Aliya , Chen Kristina , Marelli Claudio , Demchyshyn Lidia

Hypoparathyroidism is a rare disorder characterised by hypocalcaemia and hyperphosphataemia in the presence of low or inappropriately normal parathyroid hormone levels. Currently there are limited data on the burden of illness and healthcare resource utilisation (HCRU) associated with chronic hypoparathyroidism in Canada. A retrospective cohort analysis with matched controls was conducted to examine HCRU in patients with chronic hypoparathyroidism in Ontario, Canada. Data were...

ea0070aep316 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Appropriateness of the 6 mm insulin needle length comparing the glycemic control in overweight-obese and normal weight patients with type 2 diabetes – four years observational study

Gonsalves Bensley

Introduction: The length of the insulin needle in last three decades has reduced from 16 mm to 4 mm. The BMI of 10 kg/m2 difference accounts for a 4 mm difference in subcutaneous tissue thickness. We compared the glycemic control in patients switched from 4 mm needle to 6 mm needle in the Normal Weight (NW) patients (BMI < 25 kg/m2) with the Obese and Overweight (OOW) patients (BMI ≥ 25 kg/m2)</...